Briacell Therapeutics CORP Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
NASDAQ
Marc Lustig, a director of BriaCell Therapeutics, indirectly acquired 902,935 common shares and warrants through L5 Capital Inc. in a recent transaction.